Found: 31
Select item for more details and to access through your institution.
Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score–Matched Analysis.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 1, p. 1, doi. 10.1093/ofid/ofad693
- By:
- Publication type:
- Article
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP).
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 8, p. 1, doi. 10.1093/ofid/ofad374
- By:
- Publication type:
- Article
C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-08882-x
- By:
- Publication type:
- Article
C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-08882-x
- By:
- Publication type:
- Article
Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 4, p. 647, doi. 10.1007/s40121-024-00962-x
- By:
- Publication type:
- Article
Increasing of New CA-MRSA Infections Detected in people living with HIV Who Engage in Chemsex in Barcelona: An Ambispective Study.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 8, p. 2179, doi. 10.1007/s40121-023-00846-6
- By:
- Publication type:
- Article
Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years' Experience.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 2, p. 425, doi. 10.1007/s40121-022-00733-6
- By:
- Publication type:
- Article
Do ART and Chemsex Drugs Get Along? Potential Drug–Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study.
- Published in:
- Infectious Diseases & Therapy, 2022, v. 11, n. 6, p. 2111, doi. 10.1007/s40121-022-00694-w
- By:
- Publication type:
- Article
Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study.
- Published in:
- Infectious Diseases & Therapy, 2022, v. 11, n. 3, p. 1243, doi. 10.1007/s40121-022-00623-x
- By:
- Publication type:
- Article
Impact of Sexualized Substance Use and Other Risk Practices on HCV Microelimination in gbMSM Living with HIV: Urgent Need for Targeted Strategies. Results of a Retrospective Cohort Study.
- Published in:
- Infectious Diseases & Therapy, 2021, v. 10, n. 3, p. 1253, doi. 10.1007/s40121-021-00448-0
- By:
- Publication type:
- Article
Sex-based epidemiological and immunovirological characteristics of people living with HIV in current follow-up at a tertiary hospital: a comparative retrospective study, Catalonia, Spain, 1982 to 2020.
- Published in:
- Eurosurveillance (15607917), 2023, v. 28, n. 10, p. 18, doi. 10.2807/1560-7917.ES.2023.28.10.2200317
- By:
- Publication type:
- Article
The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 286, doi. 10.3390/vaccines11020286
- By:
- Publication type:
- Article
Chemsex Practices in PrEP: Beyond Addiction and Risk Toward a Healthy Sex Life—Baseline Experiences from a Hospital-Based PrEP Program in Barcelona, Spain.
- Published in:
- AIDS & Behavior, 2022, v. 26, n. 12, p. 4055, doi. 10.1007/s10461-022-03730-5
- By:
- Publication type:
- Article
Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients.
- Published in:
- Infection, 2022, v. 50, n. 5, p. 1321, doi. 10.1007/s15010-022-01833-8
- By:
- Publication type:
- Article
Experience with the use of siltuximab in patients with SARS-CoV-2 infection.
- Published in:
- Revista Española de Quimioterapia, 2021, v. 34, n. 4, p. 337, doi. 10.37201/req/045.2021
- By:
- Publication type:
- Article
Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection.
- Published in:
- Revista Española de Quimioterapia, 2021, v. 34, n. 3, p. 238, doi. 10.37201/req/037.2021
- By:
- Publication type:
- Article
Increasing emergency department admissions for chemsex-related intoxications in Barcelona, Spain, among people living with HIV: an observational study from 2018 to 2020.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effective Treatment of Lymphogranuloma venereum Proctitis With Azithromycin.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 4, p. 614, doi. 10.1093/cid/ciab044
- By:
- Publication type:
- Article
Twelve‐month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real‐world insights from BICSTaR cohorts.
- Published in:
- HIV Medicine, 2024, v. 25, n. 4, p. 440, doi. 10.1111/hiv.13593
- By:
- Publication type:
- Article
IL7 RA polymorphisms are not associated with AIDS progression.
- Published in:
- European Journal of Clinical Investigation, 2017, v. 47, n. 10, p. 719, doi. 10.1111/eci.12797
- By:
- Publication type:
- Article
Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 9, p. 2343, doi. 10.1093/jac/dkae235
- By:
- Publication type:
- Article
Effectiveness, safety and discontinuation rates of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in people with HIV using real-world data: a systematic review and meta-analysis.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 8, p. 1775, doi. 10.1093/jac/dkae138
- By:
- Publication type:
- Article
Efficacy and safety of raltegravir plus lamivudine maintenance therapy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 2, p. 255, doi. 10.1093/jac/dkad364
- By:
- Publication type:
- Article
Tolerability of bictegravir/tenofovir alafenamide/emtricitabine versus dolutegravir/lamivudine as maintenance therapy in a real-life setting.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 12, p. 2961, doi. 10.1093/jac/dkad338
- By:
- Publication type:
- Article
Clinical use and effectiveness of dolutegravir and lamivudine: a long-term, real-world, retrospective study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 8, p. 1955, doi. 10.1093/jac/dkad189
- By:
- Publication type:
- Article
Simplification from tenofovir disoproxil fumarate plus lamivudine or emtricitabine plus ritonavir-boosted protease inhibitor to ritonavir-boosted atazanavir plus lamivudine in virologically suppressed HIV-infected adults with osteopenia: a pilot study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 7, p. 1974, doi. 10.1093/jac/dkac137
- By:
- Publication type:
- Article
Real-life experience with bictegravir/emtricitabine/tenofovir alafenamide in a large reference clinical centre.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Factors associated with the use and composition of two-drug regimens in a large single-centre HIV cohort.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A randomized clinical trial comparing ritonavir-boosted lopinavir versus maraviroc each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection.
- Published in:
- 2016
- By:
- Publication type:
- journal article